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Abstract: Liquid chromatography coupled with mass spectrometry is an outstanding methodology
for fast analysis of phenolic compounds in biological samples. Twenty two compounds were quickly
and accurately identified in the methanolic extract of the Antarctic lichen Ramalina terebrata for the
first time using ultra high pressure liquid chromatography coupled with photodiode array detector
and high resolution mass spectrometry (UHPLC-PDA-Q/Orbitrap/MS/MS). In addition, the extract
and the four compounds isolated from this species were tested for the inhibitory activity of tau protein
aggregation, which is a protein involved in Alzheimer’s disease (AD). All compounds showed null
activity with the exception of parietin, which it was able to inhibit aggregation process of tau in a
concentration range between 3 µg/mL (10 µM) to 28 µg/mL (100 µM). In addition, we show how
parietin interact with tau 306VQIVYK311 hexapeptide inside of the microtubule binding domain (4R)
with the help of molecular docking experiments. Finally, the constituents present in the methanolic
extract could possibly contribute to the established anti-aggregation activity for this extract and this
in-depth analysis of the chemical composition of R. terebrata could guide further research into its
medicinal properties and potential uses.
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1. Introduction
Lichens are symbiotic associations between heterotrophic fungi and algae and/or cyanobacteria.
A peculiarity of lichen is its remarkable ability to tolerate extreme atmospheric conditions such as low
temperatures in polar zones including the Arctic and Antarctic regions; these regions are very cold; the
coldest temperature ever known on earth (´129 ˝F) was recorded in Antarctica. These environmental
conditions are responsible for the diversity of secondary metabolites produced in lichens [1–5].
Lichen substances are mainly synthesized via poly-malonyl, shikimate, and mevalonic acid pathway,
which have afforded several interesting and unique phenolic structures such as dibenzofurans,
depsides, depsidones, depsones, quinones and pulvinic acid derivatives [1–7].
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Alzheimer´s disease is the most common form of dementia. There are two main proteins involved,
β-amyloid protein and microtubule-associated tau protein. Both proteins are characterized by the
deposition of plaques and neurofibrillary tangles, respectively [8]. Physiologically, tau protein is
involved in axonal transport and microtubule stability. However, once tau is hyper-phosphorylated,
it detached from microtubules and starts to form aggregates in soma and dendrites of neuron
cells [9]. Tau is an unfolded protein whose structure has two fibril-forming motif, 275VQIINK280
and 306VQIVYK311 [10]. Besides, in order to form the fibrillar structure of tau, is required the addition
of polyanions such as heparin which suggest an important role of electrostatic interaction to form both
fibrils and aggregates [11]. These two motifs are within the microtubule binding domain of tau and are
prone to forming a cross β structure [12,13].
The determination of amyloid-like structure reveals the presence of moieties involved in β sheets
pair formation [14], this “steric zipper” is formed from short self-complementary segments of the
amyloid [15]. Thus, this formation is a central part of proto-filaments, whereas the rest of the protein
remains unfolded outside of the main axis [16]. The Q-exactive focus is a newly released hybrid high
resolution mass spectrometer used for metabolomics analysis including pesticides, herbicides, drugs,
antibiotics, small peptides and several other organic molecules [17–21]. The hyphenated Q-exactive
focus instrument combines ultra high pressure liquid chromatography coupled with photodiode array
detector (UHPLC-PDA) with an orbital trap and a high-resolution collision cell, which allows high
resolution MSn fragments [17–21].
On the other hand, molecular docking is a computational method used for the prediction of
ligand-receptor interactions and is an important tool for rational drug design [22]. Today, molecular
docking is the most important theoretical method to determine the orientation of the ligands inside
a binding site. Particularly, the challenges of molecular docking are the following: the prediction of
ligands proper orientation, the prediction of the binding energies and the prediction of novel, effective
drugs by using the structural knowledge obtained from the models [22–24]. Several examples using
these computational methods have been already reported [23–28].
The present work describes the UHPLC chromatographic fingerprints plus the isolation of the
main secondary metabolites together with the tau aggregation inhibitory activity of methanolic extract
of Ramalina terebrata. Hook. and Taylor. Based on the reported activity of fulvic acid [29] we decided to
investigate parietin, in order to demonstrate its capacity to inhibit tau protein aggregation. Moreover,
we modeled the structure of the complex between parietin and fibril-forming motif VQIVYK of tau
using docking experiments. Hence, we are able to demonstrate that parietin is able to create hydrogen
bonds (HB) with lysine residues.
2. Results and Discussion
From the methanolic extract, the following compounds were isolated: parietin 1, usnic acid 2,
atraric acid 3 and inositol 4 (Figure 1) using a combination of chromatographic techniques [30].
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Initially, the methanolic extract was screened by Thioflavin T (ThT) at concentration ranging
from 100 to 1000 µg/mL and the results reveled that at 1000 µg/mL the inhibitory activity against
aggregation process of tau protein was almost complete (Figure 2). Therefore, we have performed
the isolation of lichen substances from this extract for further testing of this activity. All isolated
compounds were tested in ThT fluorescence assay, since it has been demonstrated that ThT is able
to bind to fibrils from both synthetic and biological sources [31,32]. None of these compounds were
active to prevent tau aggregation with the exception of parietin (Figure 2).
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Figure 2. Tau aggregation process inhibited by both Ramalina extract and parietin. Black and grey
bars represent positive control (aggregation) and inhibition respectively. A paired samples-t-test was
conducted in order to compare control (aggregation) and tau inhibitors (Ramalina extract and parietin).
There was a significant difference for both Ramalina extract t (4) = 25, p < 0.05 and parietin t (4) = 3.223,
p < 0.05 (data are represented as Mean ˘ SEM).
Parietin, an orange anthraquinone pigment, is a metabolite very common in the family
Teloschistaceae. Several biological activities for this compound have been summarized [1,4]. Besides,
it is noteworthy to mention that parietin isolated from Xanthoria parietina (Linnaeus) Theodor Fries
showed antibacterial activity against S. aureus (ATCC and clinical isolate strains), antifungal activity
towards Rhizoctonia solani, Botrytis cinerea and Candida albicans. In contrast, parietin did not show any
effect regarding anticancer and antiproliferative activity [2–4]. Gauslaa and Ustvedt reported that
parietin may reduce the effect of UV adiations [2–4]. However, there is no information garding
its capacity to inhibit tau a gregation process. Furt rm re, according to our knowledge, there is no
published data on anti- ggregation propertie of lichen compounds.
The aggregation assay was performed using fragment 4R of the protein tau as positive control.
Once we tested parietin by ThT, our results showed that parietin was able to inhibit ag regation
process of tau in a concentration range between 3 µg/mL (10 µM) to 28 µg/mL (100 µM) (Figure 2)
showing a dose-response effect. The inhibitory effect of parietin at 28 µg/mL was by 75%.
Some compounds have been described for their anti-aggregating effect against over either
amyloid-β or tau protein [33–35]. In addition, anthraquinones compounds such as daunorubicin,
adriamycin and emodin inhibit tau aggregation and also diminish paired helical filaments in cells [36].
A previous report has shown that emodin, an anthraquinone related to parietin has profound effects
on aggregation process of tau protein [36], this difference could be because parietin has a methoxy
group at C-3 position instead of hydroxyl group of emodin.
There are previous evidences that negatively charged molecules such as orange-G bind specifically
to the lysine residues of tau fibril-forming motifs VQIVYK [37]. Considering that parietin has groups
with a negative charge density, we proposed that its activity against aggregation process of tau is due
to molecular interactions with fibril-forming motifs. In the complex between orange-G and VQIVYK,
the fragment of tau has a β-sheet form with the dye binding between two sheets. Considering this
information, we constructed the possible tridimensional structure of parietin in i teraction with the tau
VQIVYK motif using docking. Since we do n t have information about the preferred protonation state
of parietin forming the complex, we tested the protonation states P1 and P2 described in Materials and
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Methods section. We docked parietin structures inside a cavity formed between two steric zippers
(model A) and on the surface of one steric zipper (model B); models A and B (Figure 3).
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Figure 3. (A) Docking of parietin in protonation state P1 in the interface of two poly-306VQIVYK311
hexapeptide zippers (a,c-left). Hydrogen bounds (HBs) between parietin and lysine residues are
indicted as broken lines in the perpendicular view (b,d-right); (B) Docking of parietin in protonation
state P2 in the interface of two poly-306VQIVYK311 hexapeptide zippers (a,c-left). Hydrogen bounds
(HBs) between parietin and lysine residues are indicated as broken lines in the perpendicular view
(b,d-right).
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Docking results for parietin in protonation states P1 and P2 inside the model A, shown in
Figure 3A. The obtained models suggest that parietin could serve as inhibitor of aggregation by binding
between steric zippers preventing higher-order β-sheet interactions as orange-G [37]. The phenolic
groups and the oxygen of methoxy substituent form hydrogen bond (HB) interactions with different
VQIVYK lysine side chains. At once, the methyl group of the methoxy substituent has hydrophobic
interactions with the VYK valine. It is noteworthy that the results are comparable for both protonation
states of parietin.
The docking results for parietin in protonation states P1 and P2 inside the model B are shown in
Figure 3B. The models obtained show that both protonation states have similar orientations forming
HB interactions with lysine and glutamine side chains. Phenolic groups and carbonyl groups at
position 9 of the anthracene-9,10-dione scaffold have HB interactions with glutamine side chains, while
the oxygen of methoxy substituent and carbonyl at position 10 of the anthracene-9,10-dione scaffold
have HB interactions with lysine side chains. At the same time, methyl groups orient near VYK valine
forming hydrophobic interactions.
Regarding the HPLC fingerprint of the methanolic extract, 22 compounds were identified for the
first time in the methanolic extract of R. terebrata with the help of their characteristic UV-Vis spectra
and high-resolution mass spectrometry [38,39]. All compounds were detected in negative mode using
UHPLC-Q/Orbitrap/ESI/MS/MS (Table 1). Peak 22 was identified as parietin (molecular anion at
m/z 283.0601). Peak 21 was identified as usnic acid, which showed a [M ´ H]´ peak at m/z 343.0803.
Major diagnostic daughter MS ions of usnic acid were [M ´ H ´ CH3]´, [M ´ H ´ C4H3O2]´
and [M ´ H ´ C5H3O3]´ (328.0583, 259.0612 and 231.0663 amu, respectively). Peak 20 was identified
as lobaric acid (molecular anion at m/z 455.1712). The fragmentation of peak 20 also produced ions
at 411.1808 [M ´ H ´ CO2]´, 367.1909 [M ´ H ´ 2CO2]´, 352.1675 [M ´ H ´ 2CO2 ´ CH3]´,
and 296.1049 [M ´ H ´ 2CO2 ´ C5H11]´ confirming this depsidone. Peak 19 and 17 had the same
[M ´ H]´ ion at m/z 375.1070 with different retention time based on UHPLC at 22.04 and 23.65 min,
which were tentatively identified as placodiolic acid or pseudoplacodiolic acid, respectively. Peak 18
with a [M ´ H]´ ion at m/z 527.2290 was identified as arthoniaic acid, and peak 16 as gyrophoric acid,
which was identified by spiking experiments with an authentic standard. Peak 15 with a [M ´ H]´ ion
at m/z 497.1065 was identified as 3-hydroxyumbilicaric acid. Main daughter ion of peak 15 was at m/z
317.0652 [M ´ H ´ C9H8O4]´. Peak 8 could be tentatively identified as 4-O-dimethylbaemycesic acid
(m/z 359.0756) which produced a MS2 ion at m/z 302.0417. Ten tetrahydroxy fatty acids (peak 1–3, 5, 7,
9–11 and 13–14) and three pentahydroxy fatty acids (peak 4, 6 and 12) were tentatively identified as
the polihydroxy fatty acids reported by Huneck [30].
On the other hand, in recent years, some chemical studies belonging to Ramalina genus have been
published and most of the works have been focused on secondary metabolites [40]. Ramalina terebrata
Hook and Taylor from the Antarctic is the producer of usnic acid, ramalin, stereocalpin A and
usimines A–C [40–43]. Besides, it has been reported from the Ramalina genus isousnic acid, usninic
acid, the following depsides sekikaic acid and its 5-OH, 5-Cl derivatives, 41-O-methylsekikaic
acid, 41-O-demethylsekikaic acid, 41-O-methylnorsekikaic, 21-O-methylsekikaic, homosekikaic acid,
41-O-methylnorhomosekikaic acid, 41-O-demethylhomosekikaic acid, atranorin, chloroatranorin,
divaricatic acid, ramalinolic acid, obtusatic acid, chlorotumidulin, evernic acid, diffractaic acid,
41-O-demethylbarbatic acid, ramalinaic acid, cryptochlorophaeic acid and its 4,41-dimethyl derivative,
gyrophoric acid, trivaric acid, perlatolic acid, 41-O-methylpaludosic acid, boninic acid, stenosporic acid,
olivetoric acid, paludosic acid, lecanoric acid, and bourgeanic acid. Also, the following depsidones
salazinic acid, norstictic acid, hypoprotocetraric acid, conhypoprotocetraric acid, scopuloric acid,
protocetraric acid, connorstictic acid, cryptostictic acid, peristictic acid, variolaric acid, gangaleoidin,
physodic acid, and coquimboic acid have been isolated from Ramalina genus. Finally, the fatty acids
reported from Ramalina were oleic, palmitic, stearic, linolenic, linoleic, and myristic acids, and the
γ-lactone acids protolichesterinic, D-protolichesterinic, and nephrosterinic [40].
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Table 1. Identification of metabolites in Antarctic lichen R. terebrata by UHPLC-Q/Orbitrap/ESI/MS/MS. * Identified by spiking experiments with an authentic
compound; retention time (min); theoretical and measured mass (m/z); accuracy (ppm).
Peak Tentative Identification [M–H]´ Retention Time Theoretical Mass Measured Mass Accuracy MSn Ions
1 9,10,12,13-tetrahydroxyheptadecanoic acid C17H33O6 14.53 333.2283 333.2267 4.8 –
2 9,10,12,13-tetrahydroxyoctadecanoic acid C18H35O6 15.54 347.2439 347.2423 4.6 –
3 9,10,12,13-tetrahydroxynonadecanoic acid C19H37O6 17.45 361.2596 361.2577 5.2 343.2472
4 9,10,11,12,13-pentahydroxydocosanoic acid C22H43O7 18.54 419.3014 419.2995 4.5 –
5 9,10,12,13-tetrahydroxyeicosanoic acid C20H39O6 18.61 375.2752 375.2736 4.2 357.2628; 187.0962
6 9,10,11,12,13-pentahydroxytricosanoic acid C23H45O7 19.21 433.3165 433.3150 3.5 –
7 9,10,12,13-tetrahydroxyheneicosanoic acid C21H41O6 19.29 389.2909 389.2890 4.8 371.2782
8 4-O-dimethylbaemycesic acid C18H15O8 19.58 359.0767 359.0756 3.0 –
9 9,10,12,13-tetrahydroxyeicosanoic acid C20H39O6 19.64 375.2747 375.2735 3.2 –
10 9,10,12,13-tetrahydroxydocosanoic acid C22H43O6 19.80 403.3065 403.3047 4.4 385.2940; 215.1274
11 9,10,12,13-tetrahydroxyheneicosanoic acid C21H41O6 19.95 389.2909 389.2892 4.3 371.2782
12 9,10,11,12,13-pentahydroxytetracosanoic acid C24H47O7 20.20 447.3327 447.3306 4.7 –
13 9,10,12,13-tetrahydroxydocosanoic acid C22H43O6 20.37 403.3065 403.3043 5.4 385.2938; 187.0961
14 9,10,12,13-tetrahidroxytricosanoic acid C23H45O6 20.79 417.3222 417.3198 5.7 399.3094
15 3-hydroxyumbilicaric acid C25H21O11 21.25 497.1089 497.1065 4.8 317.0652; 167.0336
16 Gyrophoric acid * C24H19O10 21.27 467.0978 467.0962 3.4 317.0647; 167.0336; 149.0230; 123.0438
17 Placodiolic acid or Pseudoplacodiolic acid C19H19O8 22.04 375.1079 375.1070 2.4 343.0807; 259.0598; 231.0648
18 Arthoniaic acid C29H36O9 22.78 527.2281 527.2290 ´1.7 –
19 Pseudoplacodiolic acid or Placodiolic acid C19H19O8 23.65 375.1079 375.1068 2.9 343.0805; 259.0597; 231.0647
20 Lobaric acid * C25H27O8 24.82 455.1711 455.1712 ´0.2 411.1808; 367.1909; 352.1675; 296.1049
21 Usnic acid * C18H15O7 26.17 343.0818 343.0803 4.3 328.0583; 259.0612; 231.0663
22 Parietin C16H11O5 27.21 283.0612 283.0601 3.9 –
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Some lichen extracts from the genus Ramalina have displayed a wide range of biological
activities such as antimicrobial, antioxidant, antiviral, antitumoral, cytotoxicity, antiinflammatory,
and antihelmintic [30,40–46]. An acetone extract of R. farinacea demostrated activity against
Candida albicans and Candida glabrata at concentrations ranging between 3.3 to 6.6 µg/25 µL. Furthemore,
a methanolic extract of R. pollinaria showed antibacterial activity and presented MIC values between
5.62–62.5 µg/µL, while the MIC values for R. polymorpha was 62.5 µg/µL. Cansaran [44] studied five
Ramalina species, and among them the methanolic extract of R. fastigiata showed the best inhibition
against Bacillus subtilis, Enterococcus faecalis, Escherichia coli and Proteus mirabilis. Methanolic extract from
R. hossei showed better activity against Gram(+) than against Gram(´) bacteria [45]. The hexanic extract
from R. roesleri showed a high activity against S. aureus and S. mutans. In other study, the antibacterial
activity of methanolic extract of Antarctic lichen R. terebrata displayed considerable antimicrobial
activity against Bacillus subtilis (MIC 33.8 ˘ 0.15 µg/µL) and S. aureus (MIC 85.7 ˘ 6.7 µg/mL) but no
activity against C. Albicans, P. aeruginosa, and E. coli, while Paudel et al. [46] reported activity against
S. aureus. Regarding to antioxidant activity, the methanolic extracts of R. pollinaria and R. polymorpha
did no show antioxidant properties based on the DPPH method. However, a low inhibition was
showed on the oxidation of linoleic acid/β-carotene method. The methanolic extract of R. hossei and
R. conduplicans displayed antioxidant potential by the DPPH method and by the reduction of Fe+3 assay.
On the other hand, an acetonic extract of R. peruviana presented antioxidant activity on the DPPH
method (86%) and β-carotene assay (57.3%). A ethanol-water extract (1:1) of R. capitata displayed
gastroprotective activity (66%) at a dose of 200 mg/kg on the gastric damage model induced by
indomethacin, while a methanolic extract of R. cuspidata shows interesting cytotoxic activity particulary
in the cell lineages K-562, U251, DU145 and MCF7 [40].
Regarding the lichen-derived substances, usimine C has showed anti-proliferative activity
on human dermal fibroblasts [41]. Usnic acid, usimine A–C and ramalin isolated from Antarctic
lichen R. terebrata, displayed activity against B. subtilis but no activity against S. aureus, where the
values of MIC ranged from 1–26 µg/mL [40]. Ramalin showed to be a more powerful antioxidant
than butylhydroxytoluene (BHT), vitamin E, Trolox and ascorbic acid as well as a very good
antiinflammatory agent [43]. Sekikaic acid and homosekikaic acid showed IC50 values of
0.082 mg/mL and 0.276 mg/mL at the linoleic acid peroxidation assay, demonstrating that these
compounds are promising antioxidants. The antioxidant activity of atranorin, protolichesterinic
acid, usnic acid, 2-hydroxy-4-methoxy-6-propylbenzoic acid, homosekikaic acid, sekikaic acid,
2,4-dihydroxy-6-propylbenzoic acid and 2,4-dihydroxy-3,6-dimethylbenzoate isolated from the hexane
extract from R. roesleri were assessed by the DPPH method. Among the compounds, the best
antioxidant activity was exhibited by sekikaic acid, followed by homosekikaic acid. Usnic acid
has demostrated to reduce the production of Junin virus in infected Vero cells in a dependent
dose manner (EC50 9.9 µM), these results indicate that usnic acid present antiviral activity. Also,
usnic acid is not genotoxic and cytotoxic towards human lymphocyte A549, promyelocytic leukemia
HL-60, and ovarian carcinoma A2780. D-protolichesterinic acid and nephrosterinic acid showed
activity against Ehrlich carcinoma. D-protolichesterinic acid and lobaric acid are considered 5- and
12-lipoxygenase inhibitors [40].
3. Materials and Methods
3.1. Collection and Identification of Lichen Species
Ramalina terebrata was collected in “Peninsula Fildes” Antarctic region, Chile during March,
2014. Lichens were carefully removed from the rocks by abrasion. A voucher specimens were
deposited at the Extreme Natural Product laboratory, Universidad de Chile whose reference numbers
is RT-010414. R. terebrata (50 g) were dried, powdered and extracted with methanol (3 ˆ 0.5 L) to afford,
after evaporation of the solvent under vacuum, 450 mg of a dark gum.
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3.2. Extraction
The methanolic extract was subjected to Sephadex LH-20 and eluted with MeOH. Fractions
(10 mL) were monitored by TLC and combined to give two main fractions A–B. Further purification
was done for the fractions A and B. Fraction A (200 mg) was chromatographed on silica gel (50 g,
63–200 µm) using n-hexane/EtOAc mixtures (0% to 100%) giving 30 mg of parietin 1 [30] and 54 mg
of usnic acid 2 [30]. Fraction B (110 mg) was chromatographed on silica gel (30 g, 63–200 µm) using
DCM/MeOH mixtures (0% to 100%) giving 10 mg of parietin 1, 15 mg of atraric acid 3 [30] and 10 mg
of inositol 4 [30].
3.3. Tau Protein Production
Tau fragment 4R (htau244-372) was amplified by using the plasmid for htau40 as a template.
The PCR sequence was subcloned into pET-28a vector (Novagen, Madinson, WI, USA) to produce
a His-tagged protein. The recombinant fragment 4RMBD was expressed in Escherichia coli strain
BL21 (DE3) as described [29]. LB medium containing kanamycin was inoculated with a stationary
overnight culture. Bacterial culture was grown at 37 ˝C to OD600 of 0.5–0.6 and protein expression
was induced by addition of 1 mM IPTG for 4 h; and cells were pelleted and sonicated. Recombinant
tau was purified via a succession of Ni-Sepharose chromatography (equilibrated in 20 mM NaH2PO4,
500 mM NaCl, and 20 mM imidazole, pH 7.4, elution with buffer 200 mM imidazole) and side exclusion
chromatography coupled to HPLC in a Proteema 100 column (PSS, Mainz, Germany) with buffer
50 mM NaH2PO4, 300 mM NaCl, pH 6.5. The purity of the protein was verified on a Coomassie
Brilliant Blue-stained SDS-polyacrylamide gel. The protein was concentrated and stored at ´80 ˝C
until use. The concentration of purified 4RMBD was determined using the extinction coefficient at
280 nm (1520 M´1¨cm´1).
3.4. Thioflavin T Assay
The ThT fluorescence assay adopted here was modified from the reported by Pickhardt et al. [36].
Briefly, to examine the inhibition of tau aggregation, the total volume of the reaction mixture was
100 µL, which included 20 µM 4RMBD, 5 µM heparin in 100 mM sodium acetate, pH 7.0 with parietin
at different concentrations. After 20 h of incubation at 37 ˝C, addition of 100 µL of a 25 µM solution of
ThT was made and incubation continued for 1 h at room temperature prior to fluorescence reading.
Then, the fluorescence was measured in a Biotek H1 multi-mode reader (Biotek Instruments, Winooski,
VT, USA) with an excitation wavelength at 440 nm and emission wavelength of 485 nm in a 96-well
plate. Each experiment was replicated at least three times and background fluorescence was subtracted.
3.5. UHPLC-Q/Orbitrap/MS/MS
3.5.1. Instrument
A Thermo Scientific Dionex Ultimate 3000 UHPLC system equipped with a quaternary Series
RS pump and a Thermo Scientific Dionex Ultimate 3000 Series TCC-3000RS column compartments
with a Thermo Fisher Scientific Ultimate 3000 Series WPS-3000RS autosampler and a rapid separations
PDA detector controlled by Chromeleon 7.2 Software (Thermo Fisher Scientific, Bremen, Germany)
hyphenated with a Thermo high resolution Q Exactive focus mass spectrometer were used for
analysis. The chromatographic system was coupled to the MS with a Heated Electrospray Ionization
Source II (HESI II). Nitrogen (purity > 99.999%) obtained from a Genius NM32LA nitrogen
generator (Peak Scientific, Billerica, MA, USA) was employed as both the collision and damping
gas. Mass calibration for Orbitrap was performed once a week, in both negative and positive modes,
to ensure a working mass accuracy lowers than or equal to 5 ppm. Cafeine and N-butylamine
(Sigma Aldrich, Saint Louis, MO, USA) were the calibration standards for positive ions and buspirone
hydrochloride, sodium dodecyl sulfate, and taurocholic acid sodium salt were used to calibrate the
mass spectrometer. These compounds were dissolved in a mixture of acetic acid, acetonitrile, water and
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methanol (Merck Darmstadt, Hesse, Germany) and were infused using a Chemyx Fusion 100 syringe
pump. XCalibur 2.3 software and Trace Finder 3.2 (Thermo Fisher Scientific, San Jose, CA, USA) were
used for UHPLC control and data processing, respectively. Q Exactive 2.0 SP 2 from Thermo Fisher
Scientific was used to control the mass spectrometer.
3.5.2. LC Parameters
Liquid chromatography was performed using an UHPLC C18 column (Acclaim,
150 mm ˆ 4.6 mm ID, 5 m) operated at 25 ˝C. The detection wavelengths were 254, 280, 320
and 440 nm, and PDA was recorded from 200 to 800 nm for peak characterization. Mobile phases
were 1% formic aqueous solution (A) and acetonitrile (B). The gradient program (time (min), %B)
was: (0.00, 5); (5.00, 5); (10.00, 30); (15.00, 30); (20.00, 70); (25.00, 70); (35.00, 5) and 12 min for column
equilibration before each injection. The flow rate was 1.00 mL¨min´1, and the injection volume was
10 µL. Standards and lichen extracts dissolved in methanol were kept at 10 ˝C during storage in
the autosampler.
3.5.3. MS Parameters
The HESI parameters were optimized as follows: sheath gas flow rate 75 units; aux. gas unit
flow rate 20; capillary temperature 400 ˝C; aux gas heater temperature 500 ˝C; spray voltage 2500 V
(for ESI´); and S lens RF level 30. Full scan data in both positive and negative was acquired at a
resolving power of 70,000 FWHM (full width half maximum) at m/z 200. For the compounds of
interest, a scan range of m/z 100–1000 was chosen; the automatic gain control (AGC) was set at 3 ˆ 106
and the injection time was set to 200 ms. Scan-rate was set at 2 scans¨s´1. External calibration was
performed using a calibration solution in positive and negative modes before each sample series.
In addition to the full scan acquisition method, for confirmations purposes, a targeted MS/MS analysis
was performed using the mass inclusion list and expected retention times of the target analytes, with a
30 s time window, with the Orbitrap spectrometer operating both in positive and negative mode at
17,500 FWHM (m/z 200). The AGC target was set to 2 ˆ 105, with the maximum injection time of
20 ms. The precursor ions are filtered by the quadrupole which operates at an isolation window of
m/z 2. The fore vacuum, high vacuum and ultrahigh vacuum were maintained at approximately
2 mbar, from 105 and below 1010 mbar, respectively. Collision energy (HCD cell) was operated at 30 kV.
Detection was based on calculated exact mass and on retention time of target compounds, as shown in
Table 1. The mass tolerance window was set to 5 ppm for the two analysis modes.
3.6. Molecular Modeling
The current structural information about tau protein is very limited; however, our results suggest
that parietin could interact with tau fibril-forming motifs VQIINK (PHF6*), particularly with lysine
residues. The coordinates of the hexapeptide VQIVYK were extracted from the X-ray crystal structure
of tau VQIVYK segment complexed with orange-G (Protein Data Bank code 3OVL) [47,48]. The fiber
structure was prepared using the VQIVYK coordinates. Zinc atoms were removed since zinc solution
was not used in our study. We prepared two fiber structure models A and B: A contains 24 units of
hexapeptide and B contains 12 units of the hexapeptide. In model A, each member of a pair of VQIVYK
β-sheets is shifted relative to the other, without the dry interface in the typical steric zipper structure,
forming a cylindrical cavity [47,48]; docking was executed inside the cavity. The model B just contains
the half of peptides of model A, and B does not contain a cavity; therefore, the docking was executed
at surface. Using models A and B, we evaluated the interactions between the parietin and the VQIVYK
fiber structure using these models considering the presence and absence of a cavity.
For docking, we considered two protonation states of parietin: P1 with neutral phenolic groups,
and P2 with deprotonated phenolic groups. These two extreme cases allow studying the effect of
the protonation state of molecular interactions with hexapeptide VQIVYK. Both models of parietin
(P1 and P2) were sketched using Maestro’s molecular editor.
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Docking was performed using Glide method [47,48]. A grid box of 15 Å ˆ 10 Å ˆ 10 Å covered
the whole cavity in model A, and whole surface in model B. Docking parameters were used as
previously reported, a Glide extra-precision (XP) modes were explored during search. Docking
hierarchy begins with systematic conformational expansion of ligand followed by placement on
receptor site. Then, minimization of the ligand in the receptor field was carried out using the
OPLS-AA [49] force field with a distance-dependent dielectric of 2.0. Afterwards, the lowest energy
poses were subjected to a Monte Carlo procedure that samples the nearby torsional minima. The best
pose for a given ligand was determined by the Emodel score, while different compounds were ranked
using GlideScore [50]. Docking poses were analyzed by examining their relative total energy score.
The most energetically favorable conformations were selected as best poses.
3.7. Statistical Analysis
Results of statistical analysis were expressed as the mean ˘ SEM. In all experiments, statistical
differences between treatments and their respective control were determined by Paired t-test.
Significance level was set at p < 0.05. All statistical analyses were developed using GraphPad Prism 6
software (H. Motulsky, San Diego, CA, USA).
4. Conclusions
Finally, our results demonstrate that parietin has a moderate activity against the aggregation
process of tau protein, while the methanolic extract of Ramalina terebrata had also activity that could
be attributed to sinergistic effects of the compounds detected in the extract. On the other hand,
docking experiments suggest that parietin is bound to fiber-forming segment VQIVYK of tau mediated
mainly by HBs interactions with the lysine residues. Based on UHPLC-Q/Orbitrap/ESI/MS/MS,
22 compounds were identified in the methanolic extract of the Antarctic lichen Ramalina terebrata.
Finally, in-depth analysis of the chemical composition of R. terebrata could guide further research into
its medicinal properties and potential uses.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/17/8/1303/s1.
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